The antagonistic relationship between RAB7A and RAB5B may represent a defensive mechanism employed by tumor cells to counteract the inhibitory effects of BmK-M9, which could disrupt vesicular transport processes critical for tumorigenesis. Here, RAB5B is linked to neoplasm.